Furthermore, Cdk12/13 depletion significantly delayed tumor growth (Supplemental Figure 7A, bottom), extending the time to endpoint from 13 days in controls to 29 days after treatment (Figure 4A). The gene discussed is CDK12; the disease is neoplasm.